WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SOCIETY FOR WOMEN'S HEALTH RESEARCH, founded in 1990, is a community nonprofit in the Health Care sector that reported $2.5M in total revenue in fiscal year 2024. Expenses of $2.4M left a modest 6% surplus.
ADVANCE WOMEN'S HEALTH THROUGH SCIENCE, POLICY, AND EDUCATION WHILE PROMOTING RESEARCH ON SEX DIFFERENCES TO OPTIMIZE WOMEN'S HEALTH.
SCIENTIFIC, SWHR NETWORKS, AND BOSD JOURNAL - SWHR MAINTAINS A DIALOGUE WITH THE PUBLIC AND PRIVATE SECTOR RESEARCH COMMUNITIES TO EDUCATE THEM ABOUT THE NEED FOR RESEARCH IN WOMEN'S HEALTH AND THE...
SCIENTIFIC, SWHR NETWORKS, AND BOSD JOURNAL - SWHR MAINTAINS A DIALOGUE WITH THE PUBLIC AND PRIVATE SECTOR RESEARCH COMMUNITIES TO EDUCATE THEM ABOUT THE NEED FOR RESEARCH IN WOMEN'S HEALTH AND THE STUDY OF SEX DIFFERENCES. SWHR CO-OWNS THE BIOLOGY OF SEX DIFFERENCE JOURNAL (TO ENHANCE THE KNOWLEDGE OF SEX AND GENDER DIFFERENCES). SWHR CONVENES INTERDISCIPLINARY WORKING GROUP MEMBERS THAT INCLUDE RESEARCHERS, CLINICIANS, PATIENTS, AND OTHER EXPERTS TO ADDRESS GAPS IN KNOWLEDGE AND UNMET NEEDS IN WOMEN'S HEALTH ACROSS THE LIFESPAN.
POLICY AND ADVOCACY - SWHR SEEKS TO INCREASE FEDERAL FUNDING FOR BIOMEDICAL RESEARCH FOR CONDITIONS THAT AFFECT WOMEN AND FOR SEX DIFFERENCES RESEARCH. SWHR SEEKS TO ENSURE THAT WOMEN ARE INCLUDED...
POLICY AND ADVOCACY - SWHR SEEKS TO INCREASE FEDERAL FUNDING FOR BIOMEDICAL RESEARCH FOR CONDITIONS THAT AFFECT WOMEN AND FOR SEX DIFFERENCES RESEARCH. SWHR SEEKS TO ENSURE THAT WOMEN ARE INCLUDED APPROPRIATELY IN CLINICAL TRIALS, THAT TRIAL RESULTS (RESEARCH FINDINGS) ARE ANALYZED FOR SEX AND GENDER DIFFERENCES, AND THAT APPROPRIATE FUNDING IS PROVIDED FOR THE OFFICES OF WOMEN'S HEALTH AT NIH, HHS, AND FDA. FURTHERMORE, SWHR ADVOCATES FOR IMPROVED REGULATORY POLICY, COVERAGE AND PAYMENT POLICY, AND PRIVATE HEALTH PLAN POLICY TO BENEFIT THE HEALTH OF WOMEN.
COMMUNICATIONS - SWHR EDUCATES WOMEN IN THE PUBLIC ABOUT THE VALUE OF BIOMEDICAL RESEARCH AND THE LATEST FINDINGS ABOUT DISEASE PREVENTION, DIAGNOSIS, AND TREATMENT OPTIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $2,526,624 | $2,459,607 | +0.0% |
| Expenses | $2,370,173 | $1,876,324 | +0.3% |
| Net Income | $156,451 | $583,283 | -0.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KATHRYN SCHUBERT MPP CAE | PRESIDENT & CEO | 37.50 |
Officer
|
$332,813 | $57,746 | $390,559 |
| YONAS FSAHAYE MBA | CFO | 37.50 |
Officer
|
$181,499 | $17,649 | $199,148 |
| IRENE O ANINYE | CHIEF SCIENCE OFFICER | 37.50 |
Highest
|
$150,023 | $22,038 | $172,061 |
| LINDSEY N MILTENBERGER | CHIEF ADVOCACY OFFICER | 37.50 |
Highest
|
$124,028 | $16,254 | $140,282 |
| JULIE MILLER | DEVELOPMENT DIRECTOR | 37.50 |
Highest
|
$107,367 | $39,820 | $147,187 |
| GRETTA STONE | BOARD CHAIR | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| SHONTELLE DODSON PHARMD | IMMEDIATE PAST CHAIR | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| JENELLE KRISHNAMOORTHY PHD | SECRETARY-TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| PATTI COMPTON MS | EXECUTIVE COMMITTEE DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| ERIKA MILLER JD | EXECUTIVE COMMITTEE DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| JIM CAREY | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| ANNE B CROPP PHARMD BCAP | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| LINDA G GRIFFITH PHD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| JUDETTE LOUIS MD MPH | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| MARIANNE SLIGHT | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL YBARRA MD | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $2,526,624 | $2,370,173 | $3,693,359 | $156,451 |
| 2023 | $2,459,607 | $1,876,324 | $3,579,022 | $583,283 |
| 2022 | $1,941,039 | $1,596,067 | $3,008,818 | $344,972 |
| 2021 | $2,203,822 | $1,422,844 | $2,354,659 | $780,978 |
| 2020 | $1,581,715 | $1,497,282 | $1,706,481 | $84,433 |
| 2019 | $1,455,206 | $1,377,654 | $1,569,826 | $77,552 |
| 2018 | $1,479,578 | $1,423,008 | $1,521,383 | $56,570 |
Compare SOCIETY FOR WOMEN'S HEALTH RESEARCH with other nonprofits in District of Columbia and across the country.